{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "23798673",
  "DateCompleted": {
    "Year": "2013",
    "Month": "12",
    "Day": "11"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "10",
    "Day": "05"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1093/annonc/mdt234",
      "S0923-7534(19)36677-3"
    ],
    "Journal": {
      "ISSN": "1569-8041",
      "JournalIssue": {
        "Volume": "24",
        "Issue": "7",
        "PubDate": {
          "Year": "2013",
          "Month": "Jul"
        }
      },
      "Title": "Annals of oncology : official journal of the European Society for Medical Oncology",
      "ISOAbbreviation": "Ann Oncol"
    },
    "ArticleTitle": "Therapeutic windows and opportunity cost cast upon prostate cancer's fatal shore.",
    "Pagination": {
      "StartPage": "1717",
      "EndPage": "1720",
      "MedlinePgn": "1717-1720"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Developmental Therapeutics and Genitourinary Cancer Programs, University of Southern California Norris Comprehensive Cancer Center, Los Angeles."
          }
        ],
        "LastName": "Goldkorn",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Genitourinary Oncology, M. D. Anderson Cancer Center, Houston, USA."
          }
        ],
        "LastName": "Aparicio",
        "ForeName": "A M",
        "Initials": "AM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Developmental Therapeutics and Genitourinary Cancer Programs, University of Southern California Norris Comprehensive Cancer Center, Los Angeles;. Electronic address: diquinn@med.usc.edu."
          }
        ],
        "LastName": "Quinn",
        "ForeName": "D I",
        "Initials": "DI"
      }
    ],
    "PublicationTypeList": [
      "Editorial",
      "Comment"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Ann Oncol",
    "NlmUniqueID": "9007735",
    "ISSNLinking": "0923-7534"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Androstenes"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Androstenols"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antineoplastic Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Benzamides"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Nitriles"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Taxoids"
    },
    {
      "RegistryNumber": "15H5577CQD",
      "NameOfSubstance": "Docetaxel"
    },
    {
      "RegistryNumber": "2010-15-3",
      "NameOfSubstance": "Phenylthiohydantoin"
    },
    {
      "RegistryNumber": "93T0T9GKNU",
      "NameOfSubstance": "enzalutamide"
    },
    {
      "RegistryNumber": "G819A456D0",
      "NameOfSubstance": "abiraterone"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Ann Oncol. 2013 Jul;24(7):1807-12",
      "PMID": "23576708"
    },
    {
      "RefSource": "Ann Oncol. 2013 Jul;24(7):1802-7",
      "PMID": "23585511"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Androstenes"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Androstenols"
    },
    {
      "QualifierName": [
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Antineoplastic Agents"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antineoplastic Combined Chemotherapy Protocols"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Benzamides"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Bone Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Docetaxel"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Nitriles"
    },
    {
      "QualifierName": [
        "analogs & derivatives",
        "pharmacology"
      ],
      "DescriptorName": "Phenylthiohydantoin"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Prostatic Neoplasms"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Taxoids"
    }
  ]
}